Contraception en période de périménopause: indication, sécurité et avantages non contraceptifs

Translated title of the contribution: Contraception during the perimenopause: Indications, security, and non contraceptive benefits

Pablo Cantero Pérez, Jennifer Klingemann, Michal Yaron, Nicole Fournet Irion, Isabelle Streuli

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Abstract

Although patients' fertility is diminished in the period of perimenopause, they still need efficient contraception. Thorough knowledge of the physiological changes occuring during this period of transition is essential in order to provide optimal care. Until the age of 50, no contraceptive method is specifically considered unsuitable due to age alone. The choice of contraceptive needs to be adapted to the patient, assessing the individual risk factors and favouring the potential non-contraceptive advantages of the method selected. Longterm contraceptive methods (e.g., the copper intrauterine device (IUD), the Mirena IUD or a subcutaneous implant) offer an excellent solution on both levels.

Translated title of the contributionContraception during the perimenopause: Indications, security, and non contraceptive benefits
Original languageFrench
Pages (from-to)1986-1992
Number of pages7
JournalRevue Medicale Suisse
Volume11
Issue number492
StatePublished - 28 Oct 2015
Externally publishedYes

Fingerprint

Dive into the research topics of 'Contraception during the perimenopause: Indications, security, and non contraceptive benefits'. Together they form a unique fingerprint.

Cite this